Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 114-119 , June 2007

Transpulmonary Chemoembolization: A Novel Approach for the Treatment of Unresectable Lung Tumors

References 

  1. Zutic H. Bronchial carcinoma—an overview. Med Arh. 1999;53(3 suppl 1):27–31
  2. American Cancer Society. Cancer Facts & Figures 2002. Atlanta, GA: American Cancer Society; 2002;
  3. Weiss W, Boucot KR, Cooper DA. The Philadelphia pulmonary neoplasm research project (Survival factors in bronchogenic carcinoma). JAMA. 1971;216(13):2119–2123
  4. Müller M. Chirurgie für Studium und Praxis: unter Berücksichtigung des Gegenstandskataloges und der mündlichen Examina in den ärztlichen Prüfungen 2002/03/ Markus Müller und Mitarb.–6. In: Aufl.–Breisach/Rh: Med.Verl.- und Informationsdienste; 2001;p. S. 101
  5. Frommhold W, Gerhardt P. Klinisch-radiologisches Seminar, Band 17, Tumoren der Lunge. In: New York: Georg-Thiemeverlag Stuttgart; 1987;p. S 93
  6. McCormack P. Surgical resection of pulmonary metastases. Semin Surg Oncol. 1990;6:297–302
  7. Herth FJF. Epidemiologie, symptomatik und diagnostik des bronchialkarzinoms. Klinikarzt. 2005;34:202–205
  8. American Cancer Society. Cancer Facts & Figures 2004. Atlanta, GA: American Cancer Society; 2004;
  9. Plickova K, Spidlen V, Pesek M, et al. Patient survival analysis in surgery of bronchogenic carcinoma from 1986 to 1997. Rozhl Chir. 2003;82:293–299
  10. Hendriks JM, Grootenboers MJ, Schramel FM, et al. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial. Ann Thorac Surg. 2004;78:1919–1927discussion 1919-1927
  11. Vogt-Moykopf I, Bulzebruck H, Krysa S, et al. Results in surgery of pulmonary metastases. Chirurgie. 1992;118:263–271
  12. Friedel G, Pastorino U, Buyse M, et al. Resection of lung metastases: long-term results and prognostic analyses based on 5.206 cases (The International Registry of Lung Metastases). Zentralbl Chir. 1999;124:96–103
  13. Hendriks JM, Romijn S, Van Putte B, et al. Long-term results of surgical resection of lung metastases. Acta Chir Belg. 2001;101:267–272
  14. Abecasis N, Cortez F, Bettencourt A, et al. Surgical treatment of lung metastases: prognostic factors for long-term survival. J Surg Oncol. 1999;72:193–198
  15. Lanza LA, Putnam JB, Benjamin RS, et al. Response to chemotherapy does not predict survival after resection of sarcoma pulmonary metastases. Ann Thorac Surg. 1991;51:219–224
  16. Casson AG, Putnam JB, Natarajan G, et al. Five year survival after pulmonary metastasectomy for adult soft-tissue sarcoma. Cancer. 1992;69:662–668
  17. Ueda T, Uchida A, Kadama K, et al. Aggressive pulmonary metastasectomy for soft tissue sarcoma. Cancer. 1993;72:1919–1925
  18. Weksler B, Ng B, Lenert JT, et al. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg. 1993;56:209–214
  19. Mentzer SJ, Antman KH, Attinger C, et al. Selected benefits of thoracotomy and chemotherapy for sarcoma metastatic to the lung. J Surg Oncol. 1993;53:54–59
  20. Greenall MJ, Magill GB, De Cosse JJ, et al. Chemotherapy for soft tissue sarcoma. Surg Gynecol Obstet. 1986;162:193–198
  21. Dirix LJ, Oosterom AT. Diagnosis and treatment of soft tissue sarcomas in adults. Curr Opin Oncol. 1994;6:372–383
  22. Van Schil PE. Surgical treatment for pulmonary metastases. Acta Clin Belg. 2002;57:333–339
  23. Pan Y, Krueger T, Tran N. Evaluation of tumour vascularisation in two rat sarcoma models for studying isolated lung perfusion (Injection route determines the origin of tumour vessels). Eur Surg Res. 2005;37:92–99
  24. Van Putte BP, Hendriks JM, Romijn S, et al. Isolated lung perfusion for the treatment of pulmonary metastases: current mini-review of work in progress. Surg Oncol. 2003;12:187–193
  25. Romijn S, Hendriks JM, Van Putte BP, et al. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat. Eur J Cardiothorac Surg. 2005;27:1083–1085
  26. Hendriks JM, Romijn S, Van Putte B, et al. Isolated lung perfusion for the treatment of pulmonary metastatic disease: a review. Acta Chir Belg. 2005;105:338–343
  27. Muller H, Hilger R. Curative and palliative aspects of regional chemotherapy in combination with surgery. Support Care Cancer. 2003;11:1–10
  28. Van Putte BP, Hendriks JM, Romijn S, et al. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model. Ann Thorac Surg. 2002;74:893–898discussion 898
  29. Romijin S, Hendriks JM, Van Putte BP, et al. Regional differences of melphalan lung levels after isolated lung perfusion in the rat. J Surg Res. 2005;125:157–160
  30. Franke UF, Wittwer T, Lessel M, et al. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: I (Influence of perfusion pressure and hyperthermia on functional and morphological lung integrity). Eur J Cardiothorac Surg. 2004;26:792–799
  31. Demmy TL, Wagner-Mann C, Allen A. Isolated lung chemotherapeutic infusions for treatment of pulmonary metastases: a pilot study. J Biomed Sci. 2002;9:334–338
  32. Burt ME, Liu D, Abolhoda A, et al. Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial. Ann Thorac Surg. 2000;69:1542–1549
  33. Johnston MR, Minchin R, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 1995;110:368–373
  34. Pass HI, Mew DJ, Kranda KC, et al. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg. 1996;61:1609–1617
  35. Schneider P, Kampfer S, Loddenkemper C, et al. Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res. 2002;8:2463–2468
  36. Ratto GB, Toma S, Civalleri D, et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg. 1996;112:614–622
  37. Vogl TJ, Trapp M, Schroeder H, et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success—results from a liver transplantation center. Radiology. 2000;214:349–357
  38. Miller BJ, Rosenbaum AS. The vascular supply to metastatic tumors of the lung. Surg Gynecol Obstet. 1967;125:1009–1012
  39. Huppert PE, Geissler F, Duda SH, et al. Chemoembolisation des hepatozellulären karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiver repetitiver Therapie. Fortschr Roentgenstr. 1994;160:425–432
  40. Vogl TJ, Wetter A, Lindemayr S, Zangos S. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology. 2005;234:917–922
  41. Start of trial to evaluate drug eluting bead in lung cancer announced. http://www.newsrx.com/newsletters/Clinical-Oncology-Week/2006-03-20/03202006333205CO.htmlLung Cancer, March 20th, 2006
  42. Lewis AL, Gonzalez MV, Lloyd AW, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17(2 pt 1):335–342
  43. http://www.biocompatibles.co.uk/content.asp?pid=9Accessed Oct. 2007
  44. Mountain CF, Khalil KG, Hermes KF, et al. The contribution of surgery to the management of carcinomatous pulmonary metastases. Cancer. 1978;41:833–840
  45. Inoue Y, Miki C, Hiro J, et al. Improved survival using multi-modality therapy in patients with lung metastases from colorectal cancer: a preliminary study. Oncol Rep. 2005;14:1571–1576
  46. Wagner W, von Eiff M, Klinke F, et al. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study]. Strahlenther Onkol. 1995;171:390–397

PII: S1089-2516(07)00086-8

doi: 10.1053/j.tvir.2007.09.010

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 2 , Pages 114-119 , June 2007

Article Tools

* Image Usage & Resolution